APOTEX CORP.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.apotex.com

Clinical Trials

Apotex Launches First Generic Nilotinib in US with 180-Day Market Exclusivity

11 days ago

Apotex Corp. announced the launch of nilotinib capsules, the first generic version of Tasigna® in the United States, with 180 days of market exclusivity.

Home Terms & Conditions Privacy Policy